Julie Buring, ScD
Adjunct Professor
Boston University School of Public Health

ScD, Harvard University
MS, University of Washington
BA, Pomona College

Dr. Julie E. Buring is Professor of Medicine at Harvard Medical School and Brigham and Women’s Hospital; and Professor of Epidemiology at the Harvard T.H. Chan School of Public Health.

The primary focus of her research is on the prevention of chronic diseases, especially among women. Dr. Buring has been involved in the design, conduct, analysis, and interpretation of a number of large-scale randomized clinical trials of the primary prevention of cardiovascular disease, cancer and other chronic diseases. These include the Women’s Health Study, evaluating the preventive roles of aspirin and vitamin E; the Physicians' Health Study II, evaluating vitamin E, vitamin C, beta-carotene, and a multivitamin; and VITAL, an ongoing trial of vitamin D and fish oil.

Dr. Buring is actively involved in the teaching and training of students and fellows in epidemiology, both nationally and internationally, and is co-Director of an NIH T32 training grant in the Epidemiology of Cardiovascular Disease. She serves as Chair of the Institutional Review Board of Harvard Medical School.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. O'Grady TJ, Rinaldi S, Michels KA, Adami HO, Buring JE, Chen Y, Clendenen TV, D'Aloisio A, DeHart JC, Franceschi S, Freedman ND, Gierach GL, Giles GG, Lacey JV, Lee IM, Liao LM, Linet MS, McCullough ML, Patel AV, Prizment A, Robien K, Sandler DP, Stolzenberg-Solomon R, Weiderpass E, White E, Wolk A, Zheng W, Berrington de Gonzalez A, Kitahara CM. Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis. Int J Epidemiol. 2024 Feb 01; 53(1). PMID: 38110618
  2. Yu YH, Steffensen B, Chasman DI, Buring JE. Self-reported oral health is associated with systemic health outcomes and all-cause mortality. J Am Dent Assoc. 2024 Jan 24. PMID: 38276920
  3. Hsu S, Zelnick LR, Buring JE, Chou SH, Cook NR, D'Agostino D, Hoofnagle AN, LeBoff MS, Lee IM, Limonte CP, Sesso HD, Manson JE, de Boer IH. Effects of Vitamin D3 Supplementation on Incident Fractures by eGFR in VITAL. Clin J Am Soc Nephrol. 2024 Jan 24. PMID: 38265769
  4. Camargo CA, Schaumberg DA, Friedenberg G, Dushkes R, Glynn RJ, Gold DR, Mora S, Lee IM, Buring JE, Manson JE. Effect of daily vitamin D supplementation on risk of upper respiratory infection in older adults: A randomized controlled trial. Clin Infect Dis. 2023 Dec 19. PMID: 38113446
  5. Soens MA, Sesso HD, Manson JE, Fields KG, Buring JE, Lee IM, Cook NR, Kim E, Bubes V, Dushkes R, Serhan CN, Rathmell JP. The effect of vitamin D and omega-3 fatty acid supplementation on pain prevalence and severity in older adults: a large-scale ancillary study of the VITamin D and OmegA-3 triaL (VITAL). Pain. 2024 Mar 01; 165(3):635-643. PMID: 37878483
  6. Ahmad S, Moorthy MV, Lee IM, Ridker PM, Manson JE, Buring J, Demler OV, Mora S. The Mediterranean Diet, Cardiometabolic Biomarkers, and Risk of All-Cause Mortality: A 25-Year Follow-Up Study of the Women's Health Study. medRxiv. 2023 Oct 03. PMID: 37873228; PMCID: PMC10593038; DOI: 10.1101/2023.10.02.23296458;
  7. Babic A, Wang QL, Lee AA, Yuan C, Rifai N, Luo J, Tabung FK, Shadyab AH, Wactawski-Wende J, Saquib N, Kim J, Kraft P, Sesso HD, Buring JE, Giovannucci EL, Manson JE, Stampfer MJ, Ng K, Fuchs CS, Wolpin BM. Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2023 Oct 02; 32(10):1458-1469. PMID: 37555827; PMCID: PMC10592159; DOI: 10.1158/1055-9965.EPI-23-0505;
  8. Ogata S, Manson JE, Kang JH, Buring JE, Lee IM, Nishimura K, Sakata Y, Danik JS, D'Agostino D, Mora S, Albert CM, Cook NR. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease: A Novel Analysis of the VITAL Trial Using Win Ratio and Hierarchical Composite Outcomes. Nutrients. 2023 Sep 30; 15(19). PMID: 37836519; PMCID: PMC10574231; DOI: 10.3390/nu15194235;
  9. King SD, Veliginti S, Brouwers MCGJ, Ren Z, Zheng W, Setiawan VW, Wilkens LR, Shu XO, Arslan AA, Beane Freeman LE, Bracci PM, Canzian F, Du M, Gallinger SJ, Giles GG, Goodman PJ, Haiman CA, Kogevinas M, Kooperberg C, LeMarchand L, Neale RE, Visvanathan K, White E, Albanes D, Andreotti G, Babic A, Berndt SI, Brais LK, Brennan P, Buring JE, Rabe KG, Bamlet WR, Chanock SJ, Fuchs CS, Gaziano JM, Giovannucci EL, Hackert T, Hassan MM, Katzke V, Kurtz RC, Lee IM, Malats N, Murphy N, Oberg AL, Orlow I, Porta M, Real FX, Rothman N, Sesso HD, Silverman DT, Thompson IM, Wactawski-Wende J, Wang X, Wentzensen N, Yu H, Zeleniuch-Jacquotte A, Yu K, Wolpin BM, Duell EJ, Li D, Hung RJ, Perdomo S, McCullough ML, Freedman ND, Patel AV, Peters U, Riboli E, Sund M, Tjønneland A, Zhong J, Van Den Eeden SK, Kraft P, Risch HA, Amundadottir LT, Klein AP, Stolzenberg-Solomon RZ, Antwi SO. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Cancer Epidemiol Biomarkers Prev. 2023 Sep 01; 32(9):1265-1269.View Related Profiles. PMID: 37351909; PMCID: PMC10529823; DOI: 10.1158/1055-9965.EPI-23-0453;
  10. Rist PM, Buring JE, Manson JE, Sesso HD, Kurth T. History of Migraine and Risk of COVID-19: A Cohort Study. Am J Med. 2023 Nov; 136(11):1094-1098. PMID: 37598921; PMCID: PMC10592142; DOI: 10.1016/j.amjmed.2023.07.021;
Showing 10 of 857 results. Show More